U.S. markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
11.72-0.17 (-1.43%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Intermediate-term KST

Intermediate-term KST

Previous Close11.89
Open11.92
Bid11.05 x 1300
Ask13.90 x 900
Day's Range11.69 - 12.00
52 Week Range7.00 - 18.45
Volume87,901
Avg. Volume104,525
Market Cap410.287M
Beta (5Y Monthly)1.34
PE Ratio (TTM)N/A
EPS (TTM)-0.83
Earnings DateNov 05, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est23.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
    GlobeNewswire

    Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences

    BURNABY, British Columbia, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive Officer, will participate in the following virtual investor conferences: * Guggenheim Healthcare 2nd Annual Neuro/Immunology Day on Monday, November 16, 2020 * Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17, 2020 at 4:40 pm ET * Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 9:40 am ET (2:40 pm GMT) The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the “Investors” section of Xenon's website at www.xenon-pharma.com. When available, webcasts will be posted for replay following the event for 30 days.About Xenon Pharmaceuticals Inc.We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.Investor/Media Contact: Jodi Regts Xenon Pharmaceuticals Inc. Phone: 604.484.3353 Email: investors@xenon-pharma.com

  • Here's What Analysts Are Forecasting For Xenon Pharmaceuticals Inc. (NASDAQ:XENE) After Its Third-Quarter Results
    Simply Wall St.

    Here's What Analysts Are Forecasting For Xenon Pharmaceuticals Inc. (NASDAQ:XENE) After Its Third-Quarter Results

    It's shaping up to be a tough period for Xenon Pharmaceuticals Inc. (NASDAQ:XENE), which a week ago released some...

  • Xenon Pharmaceuticals Inc (XENE) Q3 2020 Earnings Call Transcript
    Motley Fool

    Xenon Pharmaceuticals Inc (XENE) Q3 2020 Earnings Call Transcript

    Joining me on today's call are Dr. Simon Pimstone, Xenon's Chief Executive Officer; and Ian Mortimer, Xenon's President and Chief Financial Officer. Following this introduction, Simon will give an overview of Xenon's clinical programs, and then Ian will provide some high-level financial commentary.